AMPing down leucine action in skeletal muscle

Journal of Nutrition

Volumn 138, Issue 12, 2008, Pages 2307-2308

  Anthony, Tracy G ^a   Anthony, Joshua C ^b  

^a Indiana University School of Medicine Evansville   (United States)

^b Mead Johnson Nutritionals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 4F; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN;

CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; NONHUMAN; NOTE; PROTEIN SYNTHESIS; SKELETAL MUSCLE;

AMINO ACIDS, BRANCHED-CHAIN; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENZYME ACTIVATION; LEUCINE; MODELS, BIOLOGICAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; RATS; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 57349128967     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.098392     Document Type: Note

References (12)

1. Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis. Curr Opin Clin Nutr Metab Care. 2008;11:222-6.
2. Pruznak AM, Kazi AA, Frost RA, Vary TC, Lang CH. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D- ribonucleoside prevents leucine stimulated protein synthesis in rat skeletal muscle. J Nutr. 2008;138:1887-94.
3. Anthony JC, Anthony TG, Kimball SR, Jefferson LS. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr. 2001;131:S856-60.
4. Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, Eguchi S, Miyamoto T, Hara K, Takehana K, et al. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem. 2007;282:20329-39.
5. Proud CG. Amino acids and mTOR signalling in anabolic function. Biochem Soc Trans. 2007;35:1187-90.
6. Hardie DG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda). 2006;21:48-60.
7. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30:214-26.
8. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through downregulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem. 2002;277:23977-80.
9. Du M, Shen QW, Zhu MJ, Ford SP. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase. J Anim Sci. 2007;85:919-27.
10. Nakashima K, Yakabe Y. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes. Biosci Biotechnol Biochem. 2007;71:1650-6.
11. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. 2008;320:1496-501.
12. Putman CT, Martins KJ, Gallo ME, Lopaschuk GD, Pearcey JA, MacLean IM, Saranchuk RJ, Pette D. Alpha-catalytic subunits of 5′AMP-activated protein kinase display fiber-specific expression and are upregulated by chronic low-frequency stimulation in rat muscle. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1325-34.